News FDA approves first trial investigating CRISPR gene editing as HIV cure Comment Leading regenerative medicine advocacy group leverages GlobalData’s datasets to highlight a record year
Comment Gastrointestinal trials and hematological disorders have highest proportion of studies disrupted by Covid-19 GlobalData Healthcare
Comment Durvalumab’s recent failure to demonstrate improved overall survival highlights challenges in clinical development for head and neck cancer GlobalData Healthcare
Comment Phase II Trial of Anti-Amyloid AR1001 Signals Little Promise for Patients with Alzheimer’s Disease GlobalData Healthcare
Comment Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market Adam Williams
Comment ASH20: uniQure presents strong data for its gene therapy EtranaDez in haemophilia B patients, aims for BLA in 2021 GlobalData Healthcare
Comment Does Arcturus’ one-shot Covid-19 vaccine have the potential to match up with leading BioNTech/Pfizer and Moderna candidates? Adam Williams
Comment Why a surge in PD-1/PD-L1 targeted combination trials is shaping the future of cancer treatment GlobalData Healthcare
Comment Registration of head-to-head psoriatic arthritis clinical trial begins the battle for second place GlobalData Healthcare
Comment The US States with the Most Covid-19 Cases, Covid-19 Trials, and Disrupted Clinical Trials GlobalData Healthcare
Comment Could improving clinical trial design result in more drug approvals for Schizophrenia? GlobalData Healthcare
Comment The increasing influence of industry sponsors along the pandemic timeline GlobalData Healthcare
Comment Interim results of the SOLIDARITY trial failed to show efficacy of repurposed drugs in mortality of hospitalized Covid-19 patients GlobalData Healthcare
Comment Positive data for Amylyx’s AMX0035 strengthen its position to enter ALS market GlobalData Healthcare
Comment Positive vote from FDA’s Advisory Committee for Alkermes’ ALKS-3831 strengthens its potential position in the Schizophrenia market GlobalData Healthcare
Comment vTv’s azeliragon study for Alzheimer’s disease and type 2 diabetes has support but some scepticism remains GlobalData Healthcare
Comment EASD 2020: New Results from the EMPEROR-Reduced Trial Demonstrate the Efficacy of Empagliflozin in the Treatment of Heart Failure With or Without Type 2 Diabetes GlobalData Healthcare
Market Data Novartis’ Intrathecal Zolgensma delay in older patients bodes well for competitors GlobalData Healthcare
Market Data EASD 2020: Once-Weekly Basal Insulin Icodec Provides Comparable Efficacy and Safety to Once-Daily Insulin Glargine U100 in Insulin-Naïve Patients with Type 2 Diabetes Inadequately Controlled by OAD GlobalData Healthcare
Comment ESMO 2020: Pfizer Gets a Chance to Reclaim Dominance of the ALK+ Lung Cancer Market GlobalData Healthcare
Comment J&J, GSK, and Vir/Alnylam present positive data for hepatitis B treatment candidates, but hopes for a cure remain muted GlobalData Healthcare
Comment Positive results for Soticlestat in Dravet syndrome but a miss in Lennox-Gastaut syndrome GlobalData Healthcare
Comment FDA regulatory application heralds a new contender in ankylosing spondylitis with AbbVie’s Rinvoq GlobalData Healthcare
Comment FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors GlobalData Healthcare